If passed, the GRAS Oversight and Transparency Act would amend several state laws related to food safety protocols and the approval of substances deemed safe for consumption. By introducing new oversight mechanisms, the bill aims to establish a more rigorous standard for companies that wish to market products containing GRAS substances. This would potentially lead to increased scrutiny and testing requirements, impacting how manufacturers approach product development and regulatory compliance in the state, thereby enhancing consumer protections.
Summary
House Bill 7291, known as the GRAS Oversight and Transparency Act, is designed to enhance government accountability and ensure transparency in the regulatory processes surrounding Generally Recognized As Safe (GRAS) substances. The bill proposed stricter guidelines for the approval and monitoring of GRAS substances to safeguard public health and promote consumer safety. Proponents of the bill argue that existing regulatory frameworks have significant gaps that can compromise the safety of food products and other consumables that utilize GRAS substances.
Contention
Despite the potential benefits, the bill has faced notable contention among stakeholders. Critics, including some business groups and food manufacturers, express concerns about the increased regulatory burden and associated costs that may arise from the new compliance requirements. They argue that the existing regulatory framework is sufficient and that the proposed changes could limit innovation and make it more challenging for companies to bring new products to market. On the other hand, advocates for the bill emphasize the necessity of protecting public health and demand strict regulation of substances that are classified as GRAS.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Reforms the organizational structure for the Department of Transportation and Development including its duties, powers, and responsibilities of officers and employees (EN INCREASE SD EX See Note)